Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 83 record(s)

Req # A-2021-001264

Adverse Drug Reaction (ADR) for INSULIN LISPRO. Report number: E2B_03868853.

Organization: Health Canada

89 page(s)
January 2022

Req # A-2021-001705

Adverse Drug Reactions (ADRs). Report numbers: 944183, 948200, 947996, 948415, 945490, 945585, 945681, 945833, 946033, 946036.

Organization: Health Canada

15 page(s)
January 2022

Req # A-2020-000790

The name of every manufacturer of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.

Organization: Health Canada

26 page(s)
January 2022

Req # A-2020-000791

Every Medical Device License of the LAP-BAND ADJUSTABLE GASTRIC BANDING (LAGB) SYSTEM (License No. 12197) medical device since the device first issuance date, that being September 20, 1999.

Organization: Health Canada

75 page(s)
January 2022

Req # A-2021-24949

Copies of all records related to the board meeting regarding the consultation results update on September 1, 2021 as referenced in Douglas Clark's calendar.

Organization: Patented Medicine Prices Review Board Canada

1 page(s)
January 2022

Req # A-2021-24950

Copies of all communication plans, strategies or similar documents prepared by PMPRB staff between May 1, 2021 and December 20, 2021.

Organization: Patented Medicine Prices Review Board Canada

7 page(s)
January 2022

Req # A-2019-001360

Adverse Reaction Report (AER). Report number: E2B_02492809.

Organization: Health Canada

64 page(s)
January 2021

Req # A-2019-001366

Adverse Reaction Report (AER). Report number: E2B_02119211.

Organization: Health Canada

29 page(s)
January 2021

Req # A-2019-001548

Adverse Reaction Report (AER). Report number: E2B_02763703.

Organization: Health Canada

6 page(s)
January 2021

Req # A-2020-000343

Adverse Reaction Report (AER) for THIOTEPA. Report number: E2B_03027201.

Organization: Health Canada

8 page(s)
January 2021
Date modified: